NTLA Historical PE Ratio image   This NTLA PE ratio history page last updated 11/11/2024
NTLA Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2024
11/7/2024
16.00-1.34-5.36NA
Q2 2024
8/8/2024
22.38-1.52-6.08NA
Q1 2024
5/9/2024
24.86-1.12-4.48NA
Q4 2023
2/22/2024
27.18-1.46-5.84NA
Q3 2023
11/9/2023
24.96-1.38-5.52NA
Q2 2023
8/3/2023
39.09-1.40-5.60NA
Q1 2023
5/4/2023
43.65-1.17-4.68NA
Q4 2022
2/23/2023
38.97-1.40-5.60NA
Q3 2022
11/3/2022
51.61-1.49-5.96NA
Q2 2022
8/4/2022
65.43-1.33-5.32NA
Q1 2022
5/5/2022
50.03-1.96-7.84NA
Q4 2021
2/24/2022
87.46-1.09-4.36NA
Q3 2021
11/4/2021
133.94-0.97-3.88NA
Q2 2021
8/5/2021
165.16-1.01-4.04NA
Q1 2021
5/6/2021
66.48-0.69-2.76NA
Q4 2020
2/25/2021
57.47-0.69-2.76NA
Q3 2020
11/5/2020
28.48-0.47-1.88NA
Q2 2020
8/6/2020
19.99-0.61-2.44NA
Q1 2020
5/7/2020
13.65-0.63-2.52NA
Q4 2019
2/27/2020
11.61-0.57-2.28NA
Q3 2019
10/31/2019
12.48-0.49-1.96NA
Q2 2019
8/1/2019
18.09-0.56-2.24NA
Q1 2019
5/2/2019
14.82-0.49-1.96NA
Q4 2018
2/27/2019
15.43-0.43-1.72NA
Q3 2018
10/31/2018
16.98-0.53-2.12NA
Q2 2018
8/1/2018
25.78-0.52-2.08NA
Q1 2018
5/1/2018
20.56-0.51-2.04NA
Q4 2017
3/14/2018
28.81-0.61-2.44NA
Q3 2017
10/31/2017
31.12-0.44-1.76NA
Q2 2017
8/1/2017
16.11-0.45-1.80NA
Q1 2017
5/2/2017
14.52-0.36-1.44NA
Q4 2016
3/14/2017
13.59-0.31-1.24NA
Q3 2016
11/1/2016
13.59-0.22-0.88NA
Q2 2016
8/4/2016
17.66-0.36-1.44NA
NTLA PE History Chart
PeriodPriceGAAPTTMPE
Q3 2024
11/7/2024
16.00-1.34-5.44NA
Q2 2024
8/8/2024
22.38-1.52-5.48NA
Q1 2024
5/9/2024
24.86-1.12-5.36NA
Q4 2023
2/22/2024
27.18-1.46-5.41NA
Q3 2023
11/9/2023
24.96-1.38-5.35NA
Q2 2023
8/3/2023
39.09-1.40-5.46NA
Q1 2023
5/4/2023
43.65-1.17-5.39NA
Q4 2022
2/23/2023
38.97-1.40-6.18NA
Q3 2022
11/3/2022
51.61-1.49-5.87NA
Q2 2022
8/4/2022
65.43-1.33-5.35NA
Q1 2022
5/5/2022
50.03-1.96-5.03NA
Q4 2021
2/24/2022
87.46-1.09-3.76NA
Q3 2021
11/4/2021
133.94-0.97-3.36NA
Q2 2021
8/5/2021
165.16-1.01-2.86NA
Q1 2021
5/6/2021
66.48-0.69-2.46NA
Q4 2020
2/25/2021
57.47-0.69-2.40NA
Q3 2020
11/5/2020
28.48-0.47-2.28NA
Q2 2020
8/6/2020
19.99-0.61-2.30NA
Q1 2020
5/7/2020
13.65-0.63-2.25NA
Q4 2019
2/27/2020
11.61-0.57-2.11NA
Q3 2019
10/31/2019
12.48-0.49-1.97NA
Q2 2019
8/1/2019
18.09-0.56-2.01NA
Q1 2019
5/2/2019
14.82-0.49-1.97NA
Q4 2018
2/27/2019
15.43-0.43-1.99NA
Q3 2018
10/31/2018
16.98-0.53-2.17NA
Q2 2018
8/1/2018
25.78-0.52-2.08NA
Q1 2018
5/1/2018
20.56-0.51-2.01NA
Q4 2017
3/14/2018
28.81-0.61-1.86NA
Q3 2017
10/31/2017
31.12-0.44-1.56NA
Q2 2017
8/1/2017
16.11-0.45-1.34NA
Q1 2017
5/2/2017
14.52-0.36-1.25NA
Q4 2016
3/14/2017
13.59-0.31NANA
Q3 2016
11/1/2016
13.59-0.22NANA
Q2 2016
8/4/2016
17.66-0.36NANA
Quotes delayed 20 minutes

Email EnvelopeFree NTLA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Intellia Therapeutics (NTLA) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

NTRA PE Ratio History
NTRB PE Ratio History
NTUS PE Ratio History
NURO PE Ratio History
NUVA PE Ratio History
NUVB PE Ratio History
NUVL PE Ratio History
NUWE PE Ratio History
NVAX PE Ratio History
NVCT PE Ratio History
How should the NTLA historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Intellia Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this NTLA Historical PE Ratio page.

What is the average historical PE for NTLA based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The NTLA historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for NTLA based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The NTLA historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the NTLA Historical PE Ratio information for Intellia Therapeutics' stock. The average NTLA historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average NTLA historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this NTLA historical PE result, against the recent PE: when this page was posted on 11/8/2024, the most recent closing price for NTLA had been 16.73, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on NTLA or any other given stock, valuation analysis for NTLA can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Intellia Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for NTLA. Thanks for visiting, and the next time you need to research NTLA Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: ETFs Holding TRGP, Funds Holding ETCG, AMNB Options Chain.

 

NTLA Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.3%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.3%.